|
| Exchange Disseminated Time | | Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 30, 2015 for which necessary intimation has already been given, will also interalia consider the matter for Allotment of 36,89,200 warrants convertible in to equal number of Equity shares on preferential basis to the promoters / promoters' group and persons other than the promoters / promoters' group pursuant to the Securities And Exchange Board of India (Issue Of Capital And Disclosure Requirements) Regulations, 2009. |
|
|